SCHEMBL2568675

SCHEMBL2568675

Cc1cc(C)c(S(=O)(=O)N2Cc3ccccc3CC2COCC(=O)NCc2ccccc2N2CCN(C)CC2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.41
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NR4A1 P22736 1/20 0.37
ESR2 Q92731 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
PRMT5 O14744 2/20 0.36
WDR77 Q9BQA1 1/20 0.36
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 2/20 0.34
HTT P42858 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2563751 0.88 EPHX2 (0.42) EPHX2MAPTKMT2AMEN1L3MBTL1
SCHEMBL2566667 0.87 EPHX2 (0.40) EPHX2MAPTKMT2AOPRD1OPRK1
SCHEMBL2566109 0.81 RAB9A (0.39) KMT2AMEN1GAA
SCHEMBL2567533 0.81 EPHX2 (0.42) EPHX2ALDH1A1OPRD1OPRK1HTT
SCHEMBL2570358 0.81 NCOA1 (0.41) KMT2AMEN1GAAMCOLN3
SCHEMBL2567253 0.80 MMP8 (0.40) EPHX2MAPTKMT2AMEN1LMNA
SCHEMBL5127128 0.79 EPHX2 (0.43) EPHX2MAPTKMT2AMEN1OPRD1
SCHEMBL2570013 0.77 BDKRB1 (0.48) EPHX2KMT2AMEN1GAANPSR1
SCHEMBL2564167 0.75 BDKRB1 (0.48) EPHX2MAPTALDH1A1KMT2AMEN1
SCHEMBL2572067 0.75 NCOA1 (0.42) KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2383267-A1 Substituted sulfonamide derivatives Grünenthal GmbH (DE) 2011-11-02 EP claimed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US claimed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US claimed
US-8435978-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-05-07 US disclosed
EP-2383267-A1 Substituted sulfonamide derivatives Grünenthal GmbH (DE) 2011-11-02 EP disclosed
US-20100324009-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-23 US disclosed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US disclosed
EP-2066659-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-06-10 EP disclosed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed
WO-2008040492-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317644-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 EPHX2 2401/4885MAPT 2195/4885ALDH1A1 1535/4885
US-20100324009-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 EPHX2 2401/4885MAPT 2195/4885ALDH1A1 1535/4885
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 EPHX2 2401/4885MAPT 2195/4885ALDH1A1 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.